Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI.

Xiaoxiao ZhaoLi SongYing WangJiannan LiJinying ZhouRunzhen ChenChen LiuPeng ZhouZhaoxue ShengYi ChenHanjun ZhaoHong-Bing Yan

Published in: Journal of inflammation research (2021)

This study demonstrated the usefulness of combined measures of PCSK9 and PTX3 to enhance risk stratification in patients with STEMI especially among patients with plaque erosion. Patients with elevation of both PCSK9 and PTX3 had a markedly increased risk of MACE.

Keyphrases

percutaneous coronary intervention
low density lipoprotein
st elevation myocardial infarction
st segment elevation myocardial infarction
patients undergoing
coronary artery disease
acute myocardial infarction
acute coronary syndrome
antiplatelet therapy
oxidative stress
atrial fibrillation
left ventricular